The safety of discontinuation of oral anticoagulation therapy after apparently successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry study
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The safety of discontinuation of oral anticoagulation therapy after apparently successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry study
Authors
Keywords
-
Journal
EUROPACE
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-08-01
DOI
10.1093/europace/euz235
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Optimal Anti-Coagulation for Enhanced-Risk Patients Post–Catheter Ablation for Atrial Fibrillation (OCEAN) trial
- (2018) Atul Verma et al. AMERICAN HEART JOURNAL
- 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
- (2017) Hugh Calkins et al. EUROPACE
- Assessment of Use vs Discontinuation of Oral Anticoagulation After Pulmonary Vein Isolation in Patients With Atrial Fibrillation
- (2017) Sara Själander et al. JAMA Cardiology
- Rationale and design of the Chinese Atrial Fibrillation Registry Study
- (2016) Xin Du et al. BMC Cardiovascular Disorders
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
- (2016) Paulus Kirchhof et al. EUROPACE
- Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries
- (2016) Leif Friberg et al. EUROPEAN HEART JOURNAL
- Anticoagulation after Catheter Ablation of Atrial Fibrillation Guided by Implantable Cardiac Monitors
- (2015) CHRISTINE S. ZUERN et al. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
- Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation
- (2015) Peter A. Noseworthy et al. Journal of the American Heart Association
- Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding: long-term follow-up in nationwide cohort of Denmark
- (2014) Deniz Karasoy et al. EUROPEAN HEART JOURNAL
- Risk of Stroke or Transient Ischemic Attack After Atrial Fibrillation Ablation with Oral Anticoagulant Use Guided by ECG Monitoring and Pulse Assessment
- (2014) MICHAEL P. RILEY et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score
- (2013) T. Jared Bunch et al. HEART RHYTHM
- Long‐term Outcomes of Catheter Ablation of Atrial Fibrillation: A Systematic Review and Meta‐analysis
- (2013) Anand N. Ganesan et al. Journal of the American Heart Association
- A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
- (2010) Ron Pisters et al. CHEST
- Moving the Tipping Point
- (2010) Mark H. Eckman et al.
- The Risk of Thromboembolism and Need for Oral Anticoagulation After Successful Atrial Fibrillation Ablation
- (2010) Sakis Themistoclakis et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
- (2009) Gregory Y.H. Lip et al. CHEST
- Biatrial anatomical reverse remodelling after radiofrequency catheter ablation for atrial fibrillation: evidence from real-time three-dimensional echocardiography
- (2008) H. Muller et al. EUROPACE
- What is the real atrial fibrillation burden after catheter ablation of atrial fibrillation? A prospective rhythm analysis in pacemaker patients with continuous atrial monitoring
- (2008) D. Steven et al. EUROPEAN HEART JOURNAL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started